NASDAQ: IBRX · Biotechnology
Over the past week, ImmunityBio (IBRX) pulled in about 64 mentions across Reddit, X and news, and the read is an Adanos Hold. The crowd averages 53% bullish across the tracked sources. Wall Street is more constructive, with 4 of 4 analysts rating IBRX a buy.
There is little buzz around IBRX this week and broad agreement on direction, which is why it reads as a Hold.
Wall Street’s 100% buy share sits next to a crowd that ranges from News at 50% to Reddit at 55%. No other tracker puts the two side by side.
4 analysts have weighed in: a Strong Buy consensus: 4 buy calls against 0 sell, with an average 12-month price target of $12.75.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits above the neutral line, momentum is mixed and the 3 sources broadly agree, so the read is Hold rather than a clear buy or sell.
Analysts sit 47 points above the crowd average of 53%, the professionals are more constructive than retail. The split is inside the crowd: Reddit reads 55% bullish while News sits at 50%, a 5-point spread that single-source trackers miss.
Over the 30-day window, ImmunityBio (IBRX) buzz held subdued around 39.1 while the price drifted up 10.4% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 7.4M shares. Over the last 7 trading days, IBRX lost 3.8%. Buzz activity in the recent week averaged 39.7 and was variable, swinging between 27.9 and 53.3. Recent volume is in line with the 30-day average, reflecting steady institutional and retail participation. Daily crowd sentiment leaned bullish on 13 of the 21 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Polymarket data for this stock this week.
Query sentiment for IBRX and 2001+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live IBRX sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Sep 04, 2026.
| Adanos signal | Hold |
|---|---|
| Analyst consensus | Strong Buy (4 / 0 / 0) |
| Crowd bullish (7d) | 53% |
| Avg price target | $12.75 |
| Most bullish source | Reddit, 55% |
| Most bearish source | News, 50% |
| Sentiment spread | 5 pts |
| Mentions (7d) | 64 |
| Market cap | $8.68B |
| P/E · Forward P/E | n/a · 113.6 |
| EPS · Beta | -$0.95 · 0.1 |
| Revenue (TTM) | $165.8M · 0% margin |
| Industry | Biotechnology |
Based on aggregated sentiment from Reddit, X and News sources, ImmunityBio (IBRX) currently carries an Adanos hold signal with 76/100 conviction. The current cross-source average reads 53% bullish across 3 active sources. Those sources contribute 64 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around ImmunityBio (IBRX) is fairly quiet with 11 mentions over the last 7 days; the 30-day context spans 12 tracked subreddits. The 7-day tone is 55% bullish; 3-day activity momentum is falling, suggesting cooling attention.
The crowd reads split on ImmunityBio (IBRX), averaging 53% bullish across 3 tracked sources over the last 7 days. The two ends of the range are Reddit at 55% bullish and News at 50%, a 5-point spread. On the professional side, 4 of 4 analysts rate IBRX a buy.
Of the 4 analysts covering ImmunityBio (IBRX), 4 rate it a buy, 0 a hold and 0 a sell, for a strong buy consensus. The average price target is $12.75. That puts the street ahead of the crowd, which averages 53% bullish.
ImmunityBio (IBRX)'s cross-source average is mixed at 53% bullish. Source readings are split: 2 sources lean bullish and 1 source sits at 50% bullish. Reddit reads 55% bullish, X reads 55% bullish and news coverage is the most negative at 50% bullish. The combined signal points to broad mixed pressure with 76/100 conviction.
The cross-source average is mixed for ImmunityBio (IBRX) at 53% bullish. Source readings are split: 2 sources lean bullish and 1 source sits at 50% bullish. The most bearish reading is news at 50% bullish. 3-day activity momentum is falling on Reddit, while x activity is rising. The hold signal carries 76/100 conviction.
X is the dominant discussion channel with 51 mentions (80% of total volume). Reddit contributes 11 mentions and News contributes 2 mentions. The cross-source average is mixed at 53% bullish, while x is the only source with rising 3-day activity. Source readings are split: 2 sources lean bullish and 1 source sits at 50% bullish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. IBRX's hold signal at 76/100 conviction reflects a mixed cross-source average at 53% bullish. Source readings are split: 2 sources lean bullish and 1 source sits at 50% bullish. It is a research shortcut, not financial advice.
The IBRX sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Hold signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key